REDWOOD CITY, Calif. (AP) — AcelRx Pharmaceuticals Inc. (ACRX) on Thursday reported a loss of $9.9 million in its fourth quarter.

The Redwood City, California-based company said it had a loss of 20 cents per share.

The drugmaker posted revenue of $740,000 in the period.

For the year, the company reported that its loss widened to $51.5 million, or $1.10 per share. Revenue was reported as $8 million.

In the final minutes of trading on Thursday, the company's shares hit $1.70. A year ago, they were trading at $3.10.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ACRX at

Automated Insights

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.